Viewing Study NCT03696550


Ignite Creation Date: 2025-12-24 @ 5:01 PM
Ignite Modification Date: 2026-01-24 @ 3:44 AM
Study NCT ID: NCT03696550
Status: COMPLETED
Last Update Posted: 2021-12-03
First Post: 2018-09-26
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Safety and PK Study of IV Eravacycline
Sponsor: Tetraphase Pharmaceuticals, Inc
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Bacterial Infections View
Keywords: